単一細胞分析市場：細胞タイプ別（ヒト、動物、微生物）、製品別（消耗品、機器）、手法別（フローサイトメトリー、NGS、顕微鏡、MS）、用途別（研究、医療）、エンドユーザー別（製薬、バイオテクノロジー、病院）-2028年までの世界予測

Single cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Global Forecast to 2028

世界のシングルセル解析市場規模は、2023年の35億米ドルから2028年には71億米ドルに達すると予測され、予測期間中の年平均成長率は15.3%である。マイクロフルイディクス、液滴ベース法、ハイスループットシーケン... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年6月22日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	332	356	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界のシングルセル解析市場規模は、2023年の35億米ドルから2028年には71億米ドルに達すると予測され、予測期間中の年平均成長率は15.3%である。マイクロフルイディクス、液滴ベース法、ハイスループットシーケンスプラットフォームなど、新しく先進的なシングルセル解析技術の開発が市場の成長を促進している。さらに、個別化医療への注目の高まり、ライフサイエンスやバイオテクノロジー研究に対する政府や民間機関の投資が、シングルセル解析製品や技術の需要を促進している。
"消耗品セグメントは、2023-2028年の予測期間中に最も高いCAGRで成長しそうである。"
製品別では、シングルセル解析市場は消耗品と機器に区分される。消耗品セグメントは予測期間中に最も高いCAGRで成長すると予測されている。この成長は、細胞ベースの研究における消耗品の需要増加に起因している。液滴ベース法やマイクロフルイディクスなどのハイスループット単一細胞分析技術では、効率的な細胞捕捉、バーコード化、処理のためにマイクロ流体チップ、試薬、ビーズなどの消耗品が必要である。これらの技術が普及し、研究者がより多くの単一細胞を同時に分析しようとするにつれて、消耗品に対する需要は増大する。サンプル調製は単一細胞分析において重要なステップであり、消耗品は細胞の分離、溶解、核酸抽出において重要な役割を果たします。細胞分離試薬、抽出キット、反応チューブなどの消耗品は、効率的で信頼性の高い単一細胞の分離と調製に必要であり、消耗品セグメントの成長に寄与している。あらかじめ最適化されたキット、プレート、チューブなどの消耗品は、実験ワークフローの合理化と標準化に役立ち、シングルセル解析の効率を改善し、ばらつきを低減する。研究者は、一貫性のある正確な結果を保証するために、シングルセルアプリケーション専用に設計された消耗品を好むことが多い。
"ヒト細胞セグメントは2023年に圧倒的なシェアを占める見込み"
細胞タイプに基づき、市場はヒト細胞、動物細胞、微生物細胞に区分される。ヒト細胞セグメントは、ヒト疾患研究への関心の高まりから、予測期間中に圧倒的なシェアを占めると予想されている。ヒトの組織や臓器内の細胞の不均一性を理解することは、様々な疾患の理解を進め、標的療法を開発する上で極めて重要である。シングルセル解析により、研究者はヒト組織内の個々の細胞間の遺伝的、エピジェネティック、表現型の違いを研究することができ、疾患メカニズムのより深い理解が可能になる。このため、ヒト細胞のシングルセル解析に対する需要が高まっています。
"次世代シーケンシングセグメントは、2023-2028年の予測期間中に最も高いCAGRで成長すると思われる。"
技法ベースで、市場はフローサイトメトリー、次世代シーケンシング、ポリメラーゼ連鎖反応、顕微鏡、質量分析、その他の技法に区分される。次世代シーケンシング分野は、予測期間中に最も高いCAGRで成長すると予測されている。この成長は、研究者が何千もの個々の細胞の遺伝物質を同時に解析することを可能にするハイスループットシーケンス機能に起因している。
"2022年、研究用途セグメントが圧倒的シェアを占めた"
アプリケーションに基づき、単一細胞解析市場は研究アプリケーションと医療アプリケーションに区分される。単一細胞分析市場では、研究用途分野が圧倒的なシェアを占めている。シングルセル解析の研究用途には、がん研究、免疫学研究、神経学研究、幹細胞研究、組織再生、ウイルス学、創薬、老化研究などの他の研究用途が含まれる。シングルセル解析は、細胞機能と相互作用に関する前例のない洞察を提供することにより、基礎生物学研究に革命をもたらした。これにより研究者は、新しい細胞タイプの発見、希少細胞集団の同定、細胞系統のマッピングが可能になる。
"学術・研究機関セグメントは、2023-2028年の予測期間に最も高いCAGRで成長しそうである。"
エンドユーザーに基づき、単一細胞分析市場は学術＆研究ラボ、バイオテクノロジー＆製薬会社、病院＆診断ラボ、細胞バンク＆IVFセンターに区分される。アカデミック＆リサーチラボ部門は、予測期間中に最も高いCAGRで成長する。研究重視の高まりは、市場成長を予測する主要因の一つである。
「アジア太平洋地域はより速いペースで成長しそうである。
単一細胞分析市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカに分けられる。2022年には、北米がシングルセル分析市場の圧倒的シェアを占めた。同地域の優位性は、同地域における支配的かつ主要な市場プレイヤーの存在、技術の進歩など様々な要因に起因する。アジア太平洋地域は、人口の増加や医療施設のインフラ整備のための政府の取り組みなど様々な要因によって、より速いペースで成長する可能性が高い。
本レポートのために実施した一次インタビューは以下のように分類できる：

- 回答者別供給側80％、需要側20
- 回答者の役職別（供給側）マネージャー - 35%、CXOおよびディレクター - 20%、エグゼクティブ - 45
- 地域別北米：25％、欧州：30％、アジア太平洋地域：30％、中南米：10％、中東・アフリカ：5
レポート掲載企業リスト

- ベクトン・ディッキンソン社（米国）
- ダナハーコーポレーション（米国）
- Merck KGaA (ドイツ)
- QIAGEN N.V.（オランダ）
- サーモフィッシャーサイエンティフィック社（米国）
- 10x Genomics（米国）
- プロメガ・コーポレーション（米国）
- イルミナ社（米国）
- バイオ・ラッド・ラボラトリーズ（米国）
- スタンダード・バイオツールズ（米）
- アジレント・テクノロジー（米）
- テカングループ（スイス(スイス）
- ザルトリウスAG（ドイツ）
- DiaSorin S.p.A.（イタリア）
- タカラバイオ（日本）
- フラクシオンバイオサイエンシズ（米国）
- メナリーニ・シリコンバイオシステムズ社（イタリア）
- バイオメリューSA（フランス）
- オックスフォード・ナノポア・テクノロジーズ（英国）
- サイテック・バイオサイエンシズ（米）
- コーニング・インコーポレイテッド（米国）
- アポジー・フロー・システムズ英国
- ナノセレクト・バイオメディカル（米）
- レアサイト社（米国）
- 株式会社オンチップ・バイオテクノロジーズ（日本(日本）。

調査範囲
この調査レポートは、シングルセル解析市場の詳細な状況を掲載しています。製品、細胞タイプ、技術、用途、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの会社概要、最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、単一細胞分析市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をより良く理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入戦略を立てるのに役立ちます。本レポートは、関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、課題、動向、機会に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します：
- シングルセル分析市場の成長に影響を与える主要な促進要因（シングルセル分析製品の技術的進歩、癌の有病率の上昇、製薬・バイオテクノロジー産業における研究開発の増加、幹細胞研究の成長、個別化医療への注目の高まり）、阻害要因（シングルセル分析製品の高コスト）、機会（シングルセルシーケンス（SCS）の高成長の可能性、シングルセル分析におけるマイクロフルイディクスの統合、アジアの新興市場）、課題（細胞療法開発のためのプロトコルとデータ統合および品質管理の標準化）の分析。
- 製品開発／イノベーション：新たに発売された製品に関する詳細な洞察、単一細胞分析市場の技術評価。
- 市場開発：有利な市場に関する包括的な情報 - 当レポートでは、さまざまな地域の単一細胞分析市場を分析しています。
- 市場の多様化：単一細胞分析市場における新製品、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。
- 競合評価：単一細胞分析市場における主要企業の市場シェア、成長戦略、製品提供について詳細に評価します。また、シングルユースバイオリアクター市場の動向を把握し、市場動向とともに主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

ページTOPに戻る

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.2.1 INCLUSIONS AND EXCLUSIONS 41
1.2.2 MARKETS COVERED 42
FIGURE 1 SINGLE-CELL ANALYSIS MARKET SEGMENTATION 42
1.2.3 YEARS CONSIDERED 43
1.3 CURRENCY 43
1.4 LIMITATIONS 43
1.5 STAKEHOLDERS 44
1.6 SUMMARY OF CHANGES 44
1.6.1 RECESSION IMPACT 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH APPROACH 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY RESEARCH 47
2.1.2 PRIMARY RESEARCH 47
FIGURE 3 SINGLE-CELL ANALYSIS MARKET: PRIMARY RESPONDENTS 48
2.2 MARKET ESTIMATION METHODOLOGY 48
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 49
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 49
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 50
FIGURE 6 INSIGHTS ON SINGLE-CELL ANALYSIS MARKET FROM PRIMARY EXPERTS 50
2.3 MARKET GROWTH RATE PROJECTIONS 51
FIGURE 7 MARKET GROWTH RATE PROJECTION, 2023–2028 52
FIGURE 8 SINGLE-CELL ANALYSIS MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 52
2.4 DATA TRIANGULATION 53
FIGURE 9 DATA TRIANGULATION METHODOLOGY 53
2.5 RESEARCH ASSUMPTIONS 54
2.6 RISK ANALYSIS 54
2.7 RECESSION IMPACT 54
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 54
3 EXECUTIVE SUMMARY 56
FIGURE 10 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 56
FIGURE 11 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 12 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 13 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 58
FIGURE 14 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 59
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET 60
4 PREMIUM INSIGHTS 61
4.1 SINGLE-CELL ANALYSIS MARKET OVERVIEW 61
FIGURE 16 TECHNOLOGICAL ADVANCEMENTS IN SINGLE-CELL ANALYSIS PRODUCTS TO DRIVE MARKET 61
4.2 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SHARE, BY PRODUCT & COUNTRY (2022) 62
FIGURE 17 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2022 62
4.3 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 62
FIGURE 18 CONSUMABLES WILL CONTINUE TO DOMINATE SINGLE-CELL ANALYSIS MARKET IN 2028 62
4.4 SINGLE-CELL ANALYSIS MARKET SHARE, BY END USER, 2023 VS. 2028 63
FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2023 63
4.5 SINGLE-CELL ANALYSIS MARKET: REGIONAL GROWTH OPPORTUNITIES 63
FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN SINGLE-CELL ANALYSIS MARKET FROM 2023 TO 2028 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
FIGURE 21 SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS 65
5.2.1 DRIVERS 65
5.2.1.1 Technological advancements in single-cell analysis products 65
TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES 65
5.2.1.2 Rising prevalence of cancer 66
TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035 67
5.2.1.3 Increasing R&D in pharmaceutical & biotechnology industries for complex diseases 68
FIGURE 22 PHARMACEUTICAL R&D SPENDING, 2014–2028 68
5.2.1.4 Growth in stem cell research 68
5.2.1.5 Growing focus on personalized medicine 69
5.2.2 RESTRAINTS 70
5.2.2.1 High cost of single-cell analysis products 70
5.2.3 OPPORTUNITIES 70
5.2.3.1 High growth potential of single-cell sequencing 70
5.2.3.2 Integration of microfluidics in single-cell analysis 71
5.2.3.3 Emerging Asian markets 71
5.2.4 CHALLENGES 71
5.2.4.1 Standardization of protocols and data integration & quality control for developing cell therapies 71
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72
FIGURE 23 REVENUE SHIFT AND NEW POCKETS FOR SINGLE-CELL ANALYSIS PROVIDERS 72
5.4 INDICATIVE PRICING ANALYSIS 72
TABLE 5 AVERAGE PRICE RANGE OF SINGLE-CELL ANALYSIS PRODUCTS (2022) 72
TABLE 6 AVERAGE SELLING PRICE OF NGS SYSTEMS (2022) 73
5.5 VALUE CHAIN ANALYSIS 73
FIGURE 24 MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES 73
5.6 SUPPLY CHAIN ANALYSIS 74
FIGURE 25 SUPPLY CHAIN ANALYSIS OF SINGLE-CELL ANALYSIS MARKET 75
5.7 ECOSYSTEM ANALYSIS 75
FIGURE 26 ECOSYSTEM ANALYSIS: SINGLE-CELL ANALYSIS MARKET 75
TABLE 7 SINGLE-CELL ANALYSIS MARKET ECOSYSTEM 76
5.8 REGULATORY ANALYSIS 77
TABLE 8 REGULATORY SCENARIO 77
5.9 PORTER’S FIVE FORCES ANALYSIS 79
TABLE 9 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 79
5.9.1 THREAT OF NEW ENTRANTS 79
5.9.2 THREAT OF SUBSTITUTES 79
5.9.3 BARGAINING POWER OF BUYERS 80
5.9.4 BARGAINING POWER OF SUPPLIERS 80
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.10 KEY CONFERENCES & EVENTS IN 2023–2024 80
TABLE 10 SINGLE-CELL ANALYSIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 80
5.11 TECHNOLOGY ANALYSIS 81
TABLE 11 COMPARISON OF SINGLE-CELL ANALYSIS TECHNOLOGIES 82
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 83
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS 83
FIGURE 28 KEY BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS 83
5.13 PATENT ANALYSIS 84
FIGURE 29 PATENTS GRANTED IN SINGLE-CELL ANALYSIS MARKET OVER LAST 10 YEARS 84
TABLE 12 INDICATIVE LIST OF PATENTS IN SINGLE-CELL ANALYSIS MARKET 85
6 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT 86
6.1 INTRODUCTION 87
TABLE 13 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 87
6.2 CONSUMABLES 87
TABLE 14 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 88
TABLE 15 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 16 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
6.2.1 BEADS 89
6.2.1.1 Wide application of beads in isolation of RNA and DNA to drive market 89
TABLE 17 SINGLE-CELL ANALYSIS BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 18 SINGLE-CELL ANALYSIS BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
6.2.2 MICROPLATES 91
6.2.2.1 Increasing demand for genomic technologies to boost market 91
TABLE 19 SINGLE-CELL ANALYSIS MICROPLATES MARKET, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 20 SINGLE-CELL ANALYSIS MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.2.3 REAGENTS 92
6.2.3.1 Advancements in single-cell genomics to increase adoption of reagents 92
TABLE 21 SINGLE-CELL ANALYSIS REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 22 SINGLE-CELL ANALYSIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.2.4 ASSAY KITS 94
TABLE 23 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 24 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 25 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
6.2.4.1 Immunoassays 95
6.2.4.1.1 Innovations in immunoassays to drive growth 95
TABLE 26 SINGLE-CELL ANALYSIS IMMUNOASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 96
TABLE 27 SINGLE-CELL ANALYSIS IMMUNOASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
6.2.4.2 Cell-based assays 97
6.2.4.2.1 Rising R&D activities in pharma and biopharma companies to drive demand 97
TABLE 28 SINGLE-CELL ANALYSIS CELL-BASED ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 29 SINGLE-CELL ANALYSIS CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
6.2.5 OTHER CONSUMABLES 98
TABLE 30 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 31 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 99
6.3 INSTRUMENTS 100
TABLE 32 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 33 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 34 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
6.3.1 FLOW CYTOMETERS 102
6.3.1.1 Technological advancements in flow cytometry to drive market 102
TABLE 35 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 36 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.3.2 NGS SYSTEMS 103
6.3.2.1 Advancements in NGS systems to support market growth 103
TABLE 37 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 38 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
6.3.3 PCR INSTRUMENTS 105
6.3.3.1 Use of PCR to amplify DNA and mRNA from single cells to study gene expression to boost market growth 105
TABLE 39 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 40 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
6.3.4 SPECTROPHOTOMETERS 106
6.3.4.1 Significant technological advancements to favor market growth 106
TABLE 41 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 42 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.3.5 CELL COUNTERS 108
6.3.5.1 Reliable and quick results to support adoption 108
TABLE 43 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 44 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
6.3.6 MICROSCOPES 109
6.3.6.1 Wide applications in cell-based research to drive adoption 109
TABLE 45 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 46 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
6.3.7 HCS SYSTEMS 111
6.3.7.1 Increasing need for multi-parametric cell analysis to drive adoption 111
TABLE 47 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 48 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
6.3.8 MICROARRAYS 112
6.3.8.1 Increasing demand in molecular biology to support market growth 112
TABLE 49 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 113
TABLE 50 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.3.9 OTHER INSTRUMENTS 114
TABLE 51 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 52 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 115
7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE 116
7.1 INTRODUCTION 117
TABLE 53 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 117
7.2 HUMAN CELLS 117
7.2.1 INCREASING CANCER RESEARCH & FUNDING TO PROPEL MARKET 117
TABLE 54 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 55 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 118
7.3 ANIMAL CELLS 119
7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET 119
TABLE 56 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 57 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 120
7.4 MICROBIAL CELLS 120
7.4.1 RISING GOVERNMENT SUPPORT TO DETECT AND COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET 120
TABLE 58 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 59 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 122
8 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE 123
8.1 INTRODUCTION 124
TABLE 60 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 124
8.2 FLOW CYTOMETRY 124
8.2.1 WIDE USAGE TO STUDY CELL MORPHOLOGIES AND IDENTIFY CANCEROUS CELLS TO DRIVE MARKET 124
TABLE 61 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 62 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 125
8.3 NEXT-GENERATION SEQUENCING 126
8.3.1 ADVANTAGES SUCH AS EFFECTIVE SCREENING AND MANAGEMENT OF HIGH-VOLUME DATA TO BOOST ADOPTION 126
TABLE 63 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 64 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 127
8.4 POLYMERASE CHAIN REACTION 127
8.4.1 ADVANCEMENTS IN PCR TECHNIQUES TO SUPPORT MARKET GROWTH 127
TABLE 65 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 66 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2021–2028 (USD MILLION) 128
8.5 MICROSCOPY 129
8.5.1 INCREASING INVESTMENTS IN CELL BIOLOGY RESEARCH TO PROPEL MARKET 129
TABLE 67 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 68 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 130
8.6 MASS SPECTROMETRY 130
8.6.1 LAUNCH OF NEW AND ADVANCED PRODUCTS TO SUPPORT MARKET GROWTH 130
TABLE 69 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 70 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 131
8.7 OTHER TECHNIQUES 132
TABLE 71 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2021–2028 (USD MILLION) 132
TABLE 72 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION) 133
9 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION 134
9.1 INTRODUCTION 135
TABLE 73 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 135
9.2 RESEARCH APPLICATIONS 135
TABLE 74 SINGLE CELL-ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 75 SINGLE CELL-ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 76 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 137
9.2.1 CANCER RESEARCH 137
9.2.1.1 Growing prevalence of cancer to support market growth 137
TABLE 77 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 78 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 138
9.2.2 IMMUNOLOGY RESEARCH 139
9.2.2.1 High incidence of infectious diseases and growing demand for advanced vaccines to propel market 139
TABLE 79 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 80 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 140
9.2.3 NEUROLOGY RESEARCH 140
9.2.3.1 Increasing incidence of neurological disorders to propel market 140
TABLE 81 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 82 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 142
9.2.4 STEM CELL RESEARCH 142
9.2.4.1 Rising investments in stem cell research to drive market 142
TABLE 83 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 84 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 143
9.2.5 OTHER RESEARCH APPLICATIONS 144
TABLE 85 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 144
TABLE 86 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 145
9.3 MEDICAL APPLICATIONS 145
TABLE 87 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 88 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 146
TABLE 89 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 146
9.3.1 NONINVASIVE PRENATAL DIAGNOSIS 147
9.3.1.1 Rising prevalence of genetic diseases to drive market 147
TABLE 90 SINGLE-CELL ANALYSIS MARKET FOR NONINVASIVE PRENATAL DIAGNOSIS, BY REGION, 2021–2028 (USD MILLION) 147
TABLE 91 SINGLE-CELL ANALYSIS MARKET FOR NON INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2021–2028 (USD MILLION) 148
9.3.2 IN VITRO FERTILIZATION 148
9.3.2.1 Increasing demand for IVF procedures to support market growth 148
TABLE 92 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2021–2028 (USD MILLION) 149
TABLE 93 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2021–2028 (USD MILLION) 149
9.3.3 CIRCULATING TUMOR CELL DETECTION 150
9.3.3.1 Rising prevalence of cancer to drive market 150
TABLE 94 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 95 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOUR CELL DETECTION, BY COUNTRY, 2021–2028 (USD MILLION) 151
10 SINGLE-CELL ANALYSIS MARKET, BY END USER 152
10.1 INTRODUCTION 153
TABLE 96 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 153
10.2 ACADEMIC & RESEARCH LABORATORIES 153
10.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET 153
TABLE 97 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 154
TABLE 98 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
10.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 155
10.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO SUPPORT MARKET GROWTH 155
TABLE 99 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 100 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 156
10.4 HOSPITALS & DIAGNOSTIC LABORATORIES 157
10.4.1 HIGH PREVALENCE OF INFECTIOUS & CHRONIC DISEASES TO DRIVE ADOPTION 157
TABLE 101 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 158
TABLE 102 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 158
10.5 CELL BANKS & IVF CENTERS 159
10.5.1 RISING DEMAND FOR PERSONALIZED & REGENERATIVE MEDICINE TO SUPPORT MARKET GROWTH 159
TABLE 103 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2021–2028 (USD MILLION) 159
TABLE 104 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 160
11 SINGLE-CELL ANALYSIS MARKET, BY REGION 161
11.1 INTRODUCTION 162
TABLE 105 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2021–2028 (USD MILLION) 162
11.2 NORTH AMERICA 162
FIGURE 30 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT 163
TABLE 106 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 107 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 108 NORTH AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 109 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 110 NORTH AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 111 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 165
TABLE 112 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 166
TABLE 113 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 114 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 115 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 116 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 168
11.2.1 US 168
11.2.1.1 Increasing R&D investments and funding to drive market 168
FIGURE 31 NIH FUNDING FOR STEM CELL RESEARCH (2011–2021) 168
TABLE 117 US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 169
TABLE 118 US: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 119 US: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 120 US: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 121 US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 171
TABLE 122 US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 171
TABLE 123 US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 124 US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 125 US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 126 US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 173
11.2.2 CANADA 173
11.2.2.1 High prevalence of hemophilia to drive market 173
TABLE 127 CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174
TABLE 128 CANADA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 129 CANADA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 130 CANADA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 131 CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 175
TABLE 132 CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 176
TABLE 133 CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 134 CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 135 CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 136 CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 178
11.2.3 NORTH AMERICA: RECESSION IMPACT 178
11.3 EUROPE 179
TABLE 137 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 138 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 179
TABLE 139 EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 140 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 141 EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 142 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 181
TABLE 143 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 182
TABLE 144 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 145 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 146 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 147 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 184
11.3.1 GERMANY 184
11.3.1.1 Government support for research funding to propel market 184
TABLE 148 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 184
TABLE 149 GERMANY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 150 GERMANY: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 151 GERMANY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 152 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 186
TABLE 153 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 187
TABLE 154 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 187
TABLE 155 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 156 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 157 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 189
11.3.2 UK 189
11.3.2.1 Favorable research conditions to support market growth 189
TABLE 158 UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 190
TABLE 159 UK: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 160 UK: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 161 UK: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 162 UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 191
TABLE 163 UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 192
TABLE 164 UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 165 UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 166 UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 167 UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 194
11.3.3 FRANCE 194
11.3.3.1 High burden of cancer to propel market 194
TABLE 168 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 194
TABLE 169 FRANCE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 170 FRANCE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 171 FRANCE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 172 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 196
TABLE 173 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 197
TABLE 174 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 197
TABLE 175 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 176 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 177 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 199
11.3.4 ITALY 199
11.3.4.1 Increasing cell biology seminars and conferences to drive market 199
TABLE 178 ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 200
TABLE 179 ITALY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 180 ITALY: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 181 ITALY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 182 ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 201
TABLE 183 ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 202
TABLE 184 ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 202
TABLE 185 ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 186 ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 187 ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 204
11.3.5 SPAIN 204
11.3.5.1 Strong R&D infrastructure and growing focus on cancer research to drive market 204
TABLE 188 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 205
TABLE 189 SPAIN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 190 SPAIN: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 191 SPAIN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 192 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 206
TABLE 193 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 207
TABLE 194 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 207
TABLE 195 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 196 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 197 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 209
11.3.6 REST OF EUROPE 209
TABLE 198 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 210
TABLE 199 REST OF EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 200 REST OF EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 201 REST OF EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 202 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 211
TABLE 203 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 212
TABLE 204 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 212
TABLE 205 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 206 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 207 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 214
11.3.7 EUROPE: RECESSION IMPACT 214

ページTOPに戻る

Table of Contents

Summary

The global single-cell analysis market size is projected to reach USD 7.1 billion by 2028 from USD 3.5 billion in 2023, at a CAGR of 15.3% during the forecast period. The development of new and advanced single-cell analysis technologies, such microfluidics, droplet-based methods, and high-throughput sequencing platforms, is driving the growth of the market. Additionally, the increasing focus on personalized medicine, governments and private organizations’ investments in life sciences and biotechnology research are driving the demand for single-cell analysis products and technologies.
“The consumables segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
On the basis of product, the single-cell analysis market is segmented into consumables and instruments. The consumables segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of consumables in cell based research. High-throughput single-cell analysis technologies, such as droplet-based methods and microfluidics, require consumables like microfluidic chips, reagents, and beads for efficient cell capture, barcoding, and processing. As these technologies gain popularity and researchers seek to analyze larger numbers of single cells simultaneously, the demand for consumables increases. Sample preparation is a critical step in single-cell analysis, and consumables play a crucial role in cell isolation, lysis, and extraction of nucleic acids. Consumables such as cell separation reagents, extraction kits, and reaction tubes are necessary for efficient and reliable single-cell isolation and preparation, contributing to the growth of the consumables segment. Consumables, including pre-optimized kits, plates, and tubes, help streamline and standardize the experimental workflow, improving efficiency and reducing variability in single-cell analysis. Researchers often prefer consumables specifically designed for single-cell applications to ensure consistent and accurate results.
“The human cells segment is expected to hold a dominant share in 2023.”
Based on the cell type, the market is segmented into human cells, animal cells and microbial cells. The human cells segment is expected to hold a dominant share during the forecast period due to increasing interest in human diseases research. Understanding the cellular heterogeneity within human tissues and organs is crucial for advancing our understanding of various diseases and developing targeted therapies. Single-cell analysis allows researchers to study the genetic, epigenetic, and phenotypic differences between individual cells within human tissues, enabling a deeper understanding of disease mechanisms. This has led to increased demand for single-cell analysis of human cells.
“The next-generation sequencing segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
On the basis of technique, the market is segmented into flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. The next-generation sequencing segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to its high-throughput sequencing capabilities, allowing researchers to analyze the genetic material of thousands of individual cells simultaneously.
“In 2022, the research applications segment held a dominant share.”
Based on application, the single-cell analysis market is segmented into research applications, and medical applications. The research applications segment held a dominant share of the single-cell analysis market. The research applications of single-cell analysis include cancer research, immunology research, neurology research, stem cell research, and other research applications such as tissue regeneration, virology, drug discovery, and research on aging. Single-cell analysis has revolutionized basic biological research by providing unprecedented insights into cellular functions and interactions. It enables researchers to discover new cell types, identify rare cell populations, and map cell lineages.
“The academic & research laboratories segment is likely to grow at highest CAGR during the forecast period of 2023-2028.”
Based on end user, the single-cell analysis market is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals and diagnostic laboratories, and cell banks & IVF centers. The academic & research laboratories segment to grow at the highest CAGR during the forecast period. Increasing imphasis on research is one of the major factors anticipated to project market growth.
“Asia Pacific region is likely to grow at faster pace.”
The single-cell analysis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of single-cell analysis market. The dominance of the region is attributable to various factors such as the presence of dominant & key market players in the region, and technological advancements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing population, and government initiatives for infrastructural improvements of healthcare facilities are driving market growth in this region.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80%, and Demand Side - 20%
• By Designation (Supply Side): Managers - 35%, CXOs & Directors - 20%, Executives- 45%
• By Region: North America -25%, Europe -30%, Asia-Pacific -30%, Latin America -10%, and Middle East and Africa -5%
Lists of Companies Profiled in the Report:

• Becton, Dickinson and Company (US)
• Danaher Corporation (US)
• Merck KGaA (Germany)
• QIAGEN N.V. (Netherlands)
• Thermo Fisher Scientific, Inc. (US)
• 10x Genomics (US)
• Promega Corporation (US)
• Illumina, Inc. (US)
• Bio-Rad Laboratories (US)
• Standard BioTools (US)
• Agilent Technologies, Inc. (US)
• Tecan Group Ltd. (Switzerland)
• Sartorius AG (Germany)
• DiaSorin S.p.A. (Italy)
• Takara Bio, Inc. (Japan)
• Fluxion Biosciences (US)
• Menarini Silicon Biosystems Inc. (Italy)
• bioMérieux SA (France)
• Oxford Nanopore Technologies (UK)
• Cytek Biosciences (US)
• Corning Incorporated (US)
• Apogee Flow Systems Ltd. (UK)
• NanoCellect Biomedical (US)
• RareCyte, Inc. (US)
• On-chip Biotechnologies Co., Ltd. (Japan).

Research Coverage:
This report provides a detailed picture of the single-cell analysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, cell type, technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall single-cell analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following pointers:
• Analysis of key drivers (Technological advancements in single-cell analysis products, rising prevalence of cancer, increasing R&D in the pharmaceutical & biotechnology industries, growth in stem cell research, growing focus on personalized medicine), restraints (High cost of single-cell analysis products), opportunities (High growth potential of single-cell sequencing (SCS), integration of microfluidics in single-cell analysis, emerging Asian markets) and challenges (Standardization of Protocols and Data Integration and Quality Control to developing cell therapies) influencing the growth of single-cell analysis market.
• Product Development/Innovation: Detailed insights on newly launched products, and technological assessment of the single-cell analysis market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the single-cell analysis market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-cell analysis market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players in the single-cell analysis market. The report also helps stakeholders understand the pulse of single-use bioreactors market and provides them information on key market drivers, restraints, challenges, and opportunities along with market trends.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（consumables）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（consumables）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?